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Salmonella enterica (S. enterica) are Gram-negative bacteria that can invade a broad range
of hosts causing both acute and chronic infections. This phenotype is related to its ability
to replicate and persist within non-phagocytic host epithelial cells as well as phagocytic
dendritic cells and macrophages of the innate immune system. Infection with S. enterica
manifests itself through a broad range of clinical symptoms and can result in asympto-
matic carriage, gastroenteritis, systemic disease such as typhoid fever and in severe cases,
death (1). Exposure to S. enterica serovars Typhi and Paratyphi exhibits clinical symptoms
including diarrhea, fatigue, fever, and temperature fluctuations. Other serovars such as
the non-typhoidal Salmonella (NTS), of which there are over 2,500, are commonly con-
tracted as, but not limited to, food-borne sources causing gastrointestinal symptoms, which
include diarrhea and vomiting. The availability of complete genome sequences for many
S. enterica serovars has facilitated research into the genetic determinants of virulence
for this pathogen. This work has led to the identification of important bacterial compo-
nents, including flagella, type III secretion systems, lipopolysaccharides, and Salmonella
pathogenicity islands, all of which support the intracellular life cycle of S. enterica. Studies
focusing on the host–pathogen interaction have provided insights into receptor activation
of the innate immune system. Therefore, characterizing the host–S. enterica interaction is
critical to understand the pathogenicity of the bacteria in a clinically relevant context. This
review outlines salmonellosis and the clinical manifestations between typhoidal and NTS
infections as well as discussing the host immune response to infection and the models
that are being used to elucidate the mechanisms involved in Salmonella pathogenicity.
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INTRODUCTION
Every year, thousands of cases of salmonellosis are reported world-
wide. However, the actual number of infections may be very differ-
ent and many times greater than expected since many milder cases
are not diagnosed or reported (http://www.cdc.gov/salmonella).
Salmonella infection or the disease associated with it, salmo-
nellosis, is most often characterized by enteritis. However, host
restricted serotypes tend to induce higher levels of bacteremia,
while some human restricted serotypes cause a systemic disease
that is characterized by mild symptoms (2). Children are the most
likely group of individuals to present salmonellosis. The rate of
diagnosed infections in children <5 years old is higher than the
rate diagnosed in all other persons. Other groups of risk, such
as the elderly and immunocompromised individuals are the most
likely to present severe forms of the disease.
Persons with diarrhea usually recover completely after a few
days of the initial infection, although it may be several months
before their bowel habits return to normal. Contrary to this could
be a small number of persons with Salmonella infections that
develop pain in their joints, irritation of the eyes, and painful uri-
nation. Taken together, these symptoms indicate a disease called
reactive arthritis. This disease can last for months or years, and
can lead to chronic arthritis, which is extremely difficult to treat.
Antibiotic treatment does not make a difference in whether or not
the person develops arthritis (3). Other types of invasive infec-
tions caused by Salmonella, such as bacteremia, osteomyelitis,
and meningitis, may also occur and in these cases may require
antimicrobial therapy (4).
The continuous evolution of Salmonella at the genetic and
genomic levels contributes to the increased virulence and resis-
tance to multiple antibiotics, leading to a phenotype of multidrug
resistance. This resistance is a significant public health concern
(5). Two major changes in the epidemiology of non-typhoidal
salmonellosis have occurred in the last century. These were the
emergence of food-borne human infections caused by Salmo-
nella enterica Enteriditis and by multidrug-resistant strains of
Salmonella enterica Typhimurium. In this century, a concerning
situation is the increased resistance that non-typhoidal Salmo-
nella (NTS) presents to fluoroquinolones and third-generation
cephalosporins. Clinical isolates showing carbapenem resistance
have also being reported (4). In terms of therapy, treatment with
antibiotics is not usually recommended for uncomplicated Sal-
monella gastroenteritis. However, recent studies indicated that
a 3–5 days therapy with ceftriaxone for patients with severe
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gastroenteritis could lead to a faster recovery. A continuous sur-
veillance scheme of Salmonella infections in both humans and
animals is of importance. A better understanding of the mecha-
nisms that can lead to the emergence of antimicrobial resistance in
Salmonella may help develop better interventional strategies that
can ultimately reduce the spread of resistant Salmonella between
humans and reservoirs identified (or not) along the food chain.
Due to the importance of Salmonella in the clinical and pub-
lic health setting, there has been a significant effort to deepen the
knowledge about pathogenic determinants of this bacterium. The
clinical relevance of the disease, associated with the advances on
the molecular tools available to study Salmonella and the devel-
opment of suitable animal models, have lead to the development
of optimal conditions to drive the scientific community to gen-
erate a large expansion of our knowledge about the pathogenesis
of Salmonella-induced enterocolitis (6). This research effort has
also generated an increased amount of information on the host
immune mechanisms that complements gaps that still exist in
fundamental research developed in this area.
The goal of this review is to discuss salmonellosis, the clin-
ical signs caused by Salmonella infections, and the advances
in our knowledge on the innate intestinal immunity. Addition-
ally, the interaction with the host and the models used to elucidate
the mechanisms triggered by the interaction of Salmonella with
the host will also be discussed.
INTERACTIONS OF SALMONELLAWITH THE GUT
MICROBIOME
The intestinal microbiome, which is host to an estimated 1× 1014
bacteria, is responsible for conferring numerous aspects of the host
response against salmonellosis (7). As many as 1,000 species of bac-
teria inhabit this niche, with the majority being classified as Gram-
positive Actinobacteria and Firmicutes as well as Gram-negative
bacteroides (8). A healthy gut microbiome provides protection
against epithelial cell invasion via a series of strategies including
the production of toxic metabolites, which have been shown to
repress the expression of Salmonella virulence genes among oth-
ers. This feature assists in the clearance of pathogens from the gut
lumen after NTS-induced diarrhea (7). Increased fecal shedding
and establishment of carrier status is commonly associated with
prolonged treatment with antimicrobial compounds as these can
have adverse effects on the composition of the gut microbiome of
an individual (8, 9). This depletion of the natural gut microbiome
may have long lasting effects and can result in an increased sus-
ceptibility to Salmonella colonization. One such example of this
scenario is S. Typhimurium,which takes advantage of the availabil-
ity of ethanolamine, a nutrient present in the microbiome, to gain a
significant growth advantage in the intestine during inflammation
over potential competing pathogens. S. Typhimurium-encoded
virulence factors have been shown to induce the production of an
alternate electron acceptor by the host, which supports anaero-
bic respiration and enables S. Typhimurium to outcompete other
fermenting gut microbes sharing the same ecological niche (10).
SALMONELLOSIS
Salmonellosis causes significant morbidity and mortality on a
global scale and occurs after the ingestion of food or water sources
that have been previously contaminated by the fecal or urinary
excretions of animals that can act as reservoirs of Salmonella (11).
Following infection with Salmonella species, a broad range of clini-
cal manifestations can be presented in a number of ways depending
on the susceptibility of the host (12, 13). These include bacteremia,
enteric fever, enterocolitis, and chronic asymptomatic carriage.
Typhoid and Paratyphoid fever, collectively termed enteric fever,
are contracted following infection with S. enterica serovars Typhi
(S. Typhi) and Paratyphi (S. Paratyphi), respectively. In contrast,
gastroenteritis is commonly associated with NTS serovars such as
Typhimurium (S. Typhimurium) and Enteritidis (S. Enteritidis).
In human beings, S. Typhi and S. Paratyphi cause typhoid
fever, a bacteremic illness, which presents in a unique manner
when compared with other Gram-negative bacteremias (14, 15).
S. Typhi has previously adapted to infect human hosts whereas
other serovars have retained a broad host preference and are
capable of infecting a range of animals causing enterocolitis
(16). Serovars of S. enterica including Choleraesuis (S. Cholerae-
suis), Dublin (S. Dublin), and S. Typhimurium can successfully
infect both human and animal hosts. However, the infection
presents differently in each. Human infection with S. Choler-
aesuis and S. Dublin commonly results in bacteremia. In mice,
S. Typhimurium causes symptoms similar to human typhoid
fever and will disseminate throughout the body of the host caus-
ing systemic illness (17, 18). Systemic infection can result in a
diverse range of clinical manifestations that include bradycar-
dia, hepatomegaly, and splenomegaly. Bacterial emboli form skin
lesions known as Rose spots that occur in approximately 30%
of typhoid fever cases. NTS serovars cause self-limiting diarrhea
and in rare cases, secondary bacteremia. Primary NTS bacteremia
has also been reported in immunocompromised hosts (19, 20).
Death from salmonellosis can be caused by perforation of the
gut and necrosis of Peyer’s patches leading to peritonitis or toxic
encephalopathy [H. (15)].
SALMONELLA SPECIES AND SUBSPECIES
Salmonella enterica are Gram-negative facultative intracellular
anaerobes that can invade a broad range of hosts causing both
acute and chronic infections by means of their ability to replicate
and persist within non-phagocytic epithelial cells as well as phago-
cytic dendritic cells and macrophages of the host innate immune
system (21, 22). The genus Salmonella comprises two species, S.
enterica and S. bongori (also referred to as subsp. V). The former is
further divided into six subspecies (as shown in Figure 1), which
are biochemically differentiated into serovars based on the com-
position of their carbohydrate, flagellar, and lipopolysaccharide
(LPS) structures. All Salmonella serotypes can be designated by an
antigenic formula based on somatic (O) and flagellar (H) antigens
in addition to capsular (Vi) antigens (16).
SALMONELLA PATHOGENICITY ISLANDS
Using ex vivo and in vivo animal models of infection, many vir-
ulence factors have been determined, which are responsible for
inducing an inflammatory immune response in the infected host.
There are two broad categories of proinflammatory stimuli that
can be observed during Salmonella infection. These are pathogen-
associated factors that stimulate the innate immune system of the
Frontiers in Immunology | Microbial Immunology October 2014 | Volume 5 | Article 481 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hurley et al. Salmonella–host interactions
FIGURE 1 | Classification of Salmonella species and subspecies.
host and virulence associated factors that exploit host processes
resulting in disease pathology.
Salmonella pathogenicity islands (SPI), historically acquired
through horizontal gene transfer events, include clusters of genes,
which encode the mechanisms through which Salmonella acts as
a virulent pathogen (23, 24). These genetic islands are located
on the bacterial chromosome or on plasmids, however, not all
serovars possess every known SPI. SPI-1 through SPI-5 are com-
mon among all S. enterica serovars (Table 1). To date, 23 SPI
have been described although the functions of those genes con-
tained within each island have not yet been completely elucidated
(25, 26). SPI-1 and SPI-2 are of particular importance in in vivo
infection (as shown in Table 1; Figure 2). The SPI encode effec-
tor proteins that are translocated directly into host cells across the
plasma membrane type III secretion systems (T3SS-1 and T3SS-2)
that provide Salmonella with the biochemical machinery to exploit
this intracellular niche. T3SSs can also be used to secrete effector
proteins into the surrounding environment to influence host cell
physiology (27, 28) (Table 1).
Salmonella pathogenicity islands-1 was originally thought to
be important as an invasion-related cluster of genes required for
oral virulence (39). More recently, additional functions have been
described for this locus. SPI-1-induced activation of the host
innate immune system results in inflammation and the recruit-
ment of polymorphonuclear (PMN) cells across the intestinal
epithelial barrier following the secretion of the effector protein
SipA by Salmonella. The latter protein is required in conjunction
with the cytokine, IL-8, and pathogen-elicited epithelial chemoat-
tractant (PEEC) to recruit neutrophils as has been reported in
cultured epithelial monolayers (40). The production of PEEC can
be induced by SipA secretion or by direct addition of SipA to cul-
tured intestinal epithelial monolayers leading to the recruitment
of basolateral neutrophils to the apical epithelial membrane (41,
42). SPI-1 effector secretion also leads to NF-κB signaling- and
caspase-1-mediated IL-1β/IL-18 activation (43). SipB, an SPI-1
encoded effector protein, which is translocated across the host cell
membrane by T3SS-1, is critical for inflammatory disease in vivo
(38) and is responsible for pyroptotic cell death, a rapid form
of programed cell death associated with antimicrobial responses
during inflammation that possesses both apoptotic and necrotic
features (44, 45). SipB binds caspase-1 (IL-1β converting enzyme)
in the cell cytosol resulting in the maturation of proinflammatory
cytokines IL-1β and IL-18 into active peptides (46). Further studies
have revealed that both caspase-1 and Ipaf deficient mice exhibit
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Table 1 | Features and functions of SPI-1 through SPI-5 identified among all S. enterica serovars.
Pathogenicity
Island
Approximate
size (kb)
Type secretion
system
Features/functions Reference
SPI-1 40 Type III
secretion
system (T3SS)
Invasion of intestinal epithelium; development of SCV;
encodes effector proteins important for: actin cytoskeleton
rearrangements; membrane ruffling; induce IL-8 and
pathogen-elicited epithelial chemoattractant secretion
Ehrbar et al. (29), Hapfelmeier et al.
(30); Ibarra et al. (31)
SPI-2 40 Type III
secretion
system (T3SS)
Survival within phagocytic cells such as macrophage; inhibits
fusions between lysosomes and SCVs; endocytic trafficking
inhibition; avoidance of NADPH oxidase-dependant killing by
macrophages; encodes effector proteins: SpiC, SseF, SseG;
encodes chaperone proteins: SscA, SscB, SseA; encodes
translocon proteins SseB, SseC, and SseD
Waterman and Holden (32),
Hapfelmeier et al. (30),
Figueira et al. (33)
SPI-3 17 Intramacrophage survival; encodes macrophage survival
protein MgtC; encodes Mg2+ transporter MgtB
Blanc-Potard and Solomon (34), Fierer
and Guiney (16), Rychlik et al. (35)
SPI4 27 Type 1 secretion
system (T1SS)
Mediates adhesion to epithelial cells; encodes genes siiA-F
(Salmonella intestinal infection genes) and SiiE ~600 kDa
non-fimbrial adhesion protein; role in oral virulence
Kiss et al. (36), Gerlach et al. (37),
Rychlik et al. (35)
SPI-5 8 Encodes SopB (secreted by T3SS of SPI-1); encodes PipB
(translocated by T3SS of SPI-2 to the SCV); important for S.
Dublin virulence and induction of proinflammatory immune
response in cattle
Zhang et al. (38), Rychlik et al. (35),
Sabbagh et al. (25)
FIGURE 2 | Schematic illustration of the genes of SPI-1 and SPI-2 indicating their functional categories is shown. In Salmonella, SPI-1 and SPI-2 encode
a range of effector proteins, secretion apparatus, and transcriptional regulators in addition to T3SS-1 and T3SS-2.
an increased susceptibility to typhoid fever, thereby demonstrating
the protective proinflammatory role played by caspase-1 (47).
The proinflammatory activity of SPI-2 while less characterized
has been shown to be important for intracellular persistence and
systemic virulence in murine typhoid fever in addition to evading
host phagosome oxidation mechanisms (48). T3SS-2 plays an
important role in inflammatory disease, highlighting the involve-
ment of SPI-2 in the onset of enterocolitis. SPI-2 functions by
enabling the translocation of effectors across the membrane of
the Salmonella-containing vacuole (SCV) in infected host cells.
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The genes encoding T3SS-2 are controlled by two-component
regulatory systems such as OmpR–EnvZ and the SPI-2 encoded
SsrA–SsrB. As many as 28 SPI-2 encoded effectors have been iden-
tified to date with many of these currently of unknown function
such as SseK1-3 and SteA–B, D–E. SseF is involved in SCV local-
ization and Salmonella-induced filament (Sif) formation. PipB2 is
responsible for kinesin-1 recruitment to the SCV and Sif extension,
whereas SspH2 and SteC are recruited to and involved in the for-
mation of the SCV-associated F-actin meshwork, respectively (49).
The Toll-like receptors (TLR) adapter, myeloid differentiation pri-
mary response gene (MyD88) is required for SPI-1 independent
intestinal inflammation in mice (30).
THE INTERACTION OF SALMONELLAWITH THE HOST
Salmonella invades both phagocytic and non-phagocytic cells
including mononuclear phagocytic cells present in the lymphoid
follicles, liver, and spleen. Epithelial cells and phagocytic cells
such as dendritic cells, neutrophils, and macrophages identify
specific pathogen-associated molecular pattern (PAMP) motifs
and endogenous danger-associated molecular pattern molecules
(DAMPs) present in the bacteria. Pattern-recognition receptors
(PRRs), which include NOD-like receptors (NLRs) and TLRs,
comprise the early components of the immune system that func-
tion to detect invading pathogens through PAMPs and DAMPs
and signal to recruit and activate phagocytic cells such as neu-
trophils and macrophages (50, 51). These receptors trigger an
immune response and are key to establishing an important net-
work between the innate and adaptive immune systems. Bacterial
DNA, flagella, and LPS are examples of PAMPs, which activate
TLR4, TLR5, and TLR9 signaling in the host. LPS-induced TLR4
activation is important for triggering the inflammatory responses
of the host. It also plays an important role in mounting an inflam-
matory response to intravenously administered LPS. Mice with
mutations in TLR4-encoding genes exhibit an increased suscep-
tibility to Salmonella infection irrespective of other Salmonella
resistance loci (52, 53). Additionally, LPS plays an important role
in the onset of sepsis during systemic infection as observed by its
role in inducing inflammation in macrophages (54).
The immune system can be divided into two main parts: the
innate or non-specific and the adaptive or specific components.
The innate immune system is the first host challenge presented
to invading pathogens whereas the adaptive immune system pro-
vides further protection in addition to an immunological memory,
which enables a faster response upon repeat exposure to the same
pathogen or antigen. In addition to cellular components such as
phagocytic cells, there are humoral elements such as the com-
plement system that make up the innate immune system. Addi-
tionally, anatomical features like the mammalian skin layer act as
physical barriers to infection. The interplay between the innate
and adaptive immune systems, including different types of cells
and molecules such as cytokines and antibodies, form the totality
of the host immunity.
Leukocytes of the innate immune system include phagocytic
cells, namely dendritic cells, macrophages, and neutrophils, which
can engulf foreign antigens, particles, or pathogens. These phago-
cytic cells are recruited following the release of specific cytokine
signals. These cells serve an important role in the activation of
the adaptive immunity, which usually assumes the presence of
lymphocytes (55). Other cells, such as basophils, eosinophils, and
mast cells are also part of the host innate immune system that
contributes to the innate immunity.
During the initial stages of an inflammatory response, neu-
trophils and macrophages are recruited to the site of infection.
Neutrophils phagocytose the invading pathogens and kill them
intracellularly. Similarly, macrophages and newly recruited mono-
cytes, which will differentiate into macrophages following sig-
naling or chemical stimulation, also function by phagocytosing
and killing the pathogens at the intracellular level. Furthermore,
macrophages are capable of killing infected or self-target cells and
can also induce further downstream immune responses through
the presentation of surface antigens to signal and recruit other cells
and cell types (56).
A common feature of salmonellosis is the notable inflamma-
tory response elicited by the host innate immune system. Both the
host and pathogen have evolved defense mechanisms that result
in a complex cross-talk that culminates with the induction of the
host immune response.
Salmonella species can cross the epithelial barrier by passive
transport facilitated by dendritic cells, which extend pseudopods
between local epithelial cells, or by active invasion. Upon reach-
ing the lower intestine, the bacteria will adhere to the mucosal
membranes and invade epithelial cells (57). One such site where
this occurs is the microfold (M) cells of Peyer’s patches that are
located in the small intestine where the bacteria will translocate
across the epithelial barrier to the underlying follicles and mesen-
teric lymph nodes of the lymphoid tissue (58) (Figures 3A,B).
During sustained bacteremia, secondary infections can occur due
to the dissemination of the bacteria to other organs such as the
gall bladder, liver, and spleen. The gall bladder serves as a reservoir
in chronic cases of S. Typhi and S. Typhimurium infection (59,
60). Infection by invading bacteria can originate from both the
blood and/or retrograde bile. Biofilm formation on gallstones is a
reported avenue through which chronic carriage and shedding of
Salmonella species can be established. These events set in motion
a cycle of infection wherein bacteria basolaterally reinvade epithe-
lial cells of the intestinal wall or are shed in feces. In time, the
symptoms of salmonellosis will resolve. However, asymptomatic
carriage of the bacteria can occur in patients for months or years
with the potential to relapse in the future.
TRANSMISSION OF INFECTION
Following the ingestion of contaminated food, these bacteria will
colonize the intestines by invading dendritic cells and entero-
cytes of the intestinal epithelium barrier. Salmonella species, which
are successful in passing this barrier are confronted by proximal
macrophages and may be phagocytosed, or actively invade the
macrophages, using T3SS-1 and fimbriae, among other bacterial
surface adhesins [H. (15)] (Figure 3Ci).
After being internalized by macrophages, Salmonella then
reside within a membrane bound compartment distinct from the
phagosome and lysosome known as the SCV. In this cellular com-
partment, Salmonella can survive and replicate in the absence of
host antimicrobial defense mechanisms, thereby evading endoso-
mal fusion with the NADPH oxidase complex (61) (Figure 3Cii).
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FIGURE 3 | Schematic illustration of the infection of epithelial cells of
the lower intestine and macrophages by Salmonella is shown.
(A) The complex membrane structure of Salmonella allows it to survive
until reaching the epithelial cell wall of the host in the lower intestine.
(B) Salmonella then translocate across M cells of Peyer’s patches or
actively invade epithelial cells by the secretion of effector proteins through
the SPI-1 encoded T3SS-1. (C) (i) After crossing the epithelial barrier,
Salmonella are engulfed by proximal macrophages that will secrete
effector proteins into the cytosol of the cell via the SPI-2 encoded T3SS-2
and prevent fusion of the phagosome with the lysosome. (ii) Within the
SCV, Salmonella will proliferate resulting in cytokine secretion by the
macrophage. (iii) Finally, the macrophage will undergo apoptosis, and
Salmonella will escape the cell to basolaterally reinvade epithelial cells or
other phagocytic cells of the host innate immune system.
From within the SCVs, SPI-2 genes are expressed encoding T3SS-2,
which enables Salmonella to translocate a range of effector pro-
teins into the cytoplasm of the host cell including SigD/SopB,
SipA, SipC, SodC-1, SopE2, and SptP leading to the rearrangement
of the actin cytoskeleton. T3SS-2 has been described as neces-
sary for systemic virulence in murine models and survival within
macrophages (62). In contrast, systemic translocation of S. Dublin
in cattle requires T3SS-1 but not T3SS-2 (63).
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CYTOKINE RESPONSES AND SIGNALING
Proinflammatory cytokines including the interleukins (IL-1β and
IL-6), interferons (IFN-γ), and tumor necrosis factor (TNF-α) are
synthesized and these act to promote systemic inflammation (64–
67). IFN-γ, also known as macrophage activating factor (MAF),
plays an important role in persistent infection as it influences the
duration of macrophage activation. Secretion of IFN-γ is depen-
dent on IL-18, also known as interferon gamma inducing factor,
and is essential for establishing an early host resistance to infection
with Salmonella (65, 68).
Macrophages are involved in both the innate and adaptive
immune responses. Following exposure to specific cytokines, they
undergo either classical (Th1) or alternative (Th2) activation.
Classical activation by bacterial LPS or IFN-γ leads to alter-
ation in the secretory profile of the cells through production of
organic nitrate compounds such as nitric oxide (NO). Alterna-
tive activation by IL-4, IL-10, or IL-13 leads to the production
of polyamines and proline inducing proliferation and collagen
production, respectively. The presence of Salmonella within these
cells leads to cytokine secretion and an inflammatory reaction or
programed cell death through apoptosis (69, 70) (Figure 3Ciii).
Cytokine signaling, induced by the interaction of the host cells
and bacteria, is crucial to the development and progression of
salmonellosis. Cytokines are responsible for regulating both the
innate and adaptive host immune responses. The equilibrium
between pro- and anti-inflammatory cytokines controls the infec-
tion preventing damage to the host from prolonged inflammation.
In vitro cell culture of bone marrow derived macrophages and pri-
mary cell lines have shown that Salmonella promotes chemokine
and cytokine synthesis in both dendritic and epithelial cells as
well as macrophages (69, 71, 72). Cytokines have a broad range
of effects upon the host cell during infection. Chemokine C–C
motif ligand (CCL2), IFN-γ, IL-12, IL-18, TNF-α, and transform-
ing growth factor (TGF-β) confer protection during infection
(73). Conversely, IL-4 and IL-10 interfere with the host defense
mechanisms (74).
ENVIRONMENT ADAPTATION
Salmonella adapt to the intracellular environment of phago-
cytic cells during infection. The transition from extracellular to
intravacuolar environments involves global modulation of bacte-
rial gene expression. The complete transcriptional landscape of
intracellular S. Typhimurium following macrophage infection has
been previously reported (75, 76). During replication in murine
J774 macrophages, 919 of 4,451 S. Typhimurium genes are dif-
ferentially expressed. Many of the in vivo-regulated genes are
of unknown function suggesting novel macrophage-associated
functions for intracellular growth (77).
It has been shown previously that S. Typhimurium requires
glycolysis for infection of mice and macrophages and that glu-
cose transport is required for replication within macrophages.
During systemic infection of mice, S. Typhimurium replicates
in macrophages within the SCV. Mutation of the pfkAB-
encoded phosphofructokinase, the rate-limiting step in glycol-
ysis, severely attenuates replication and survival within RAW
264.7 macrophages. Mutants with perturbed phosphoenolpyru-
vate:carbohydrate phosphotransferase systems or those unable to
catabolize glucose exhibit reduced replication within RAW 264.7
macrophages (78).
Salmonella upregulates RpoS-dependent stress responses as
well as other response mechanisms when challenged to grow
in sublethal concentrations of the bile salt sodium deoxycholate
(DOC). The latter is known to disrupt membranes, denature pro-
teins, and damage DNA (79). It has been previously shown that
Salmonella can pre-adapt to several stresses in order to survive
the adverse conditions encountered, such as those encountered in
a contaminated food matrix and any associated food production
processes. Similarly, the subsequent ingestion of the bacterium by
the host presents an array of challenges to the organism including
acid, cold, osmotic, and peroxide stress (80).
PATHOLOGICAL SYMPTOMS
Prolonged activation of the innate immune system can have
adverse effects, which include intravascular coagulation, systemic
inflammation, and tissue injury. In severe cases, these symptoms
can lead to death. An aggressive proinflammatory response to
infection with Salmonella is not a common occurrence and it
arises rarely in patients with typhoid fever. Unusual cases leading
to intravascular coagulation do not present with readily recogniz-
able clinical signs (81, 82). In these cases, the blood serum levels
of IL-1β and TNF-α are lower when compared to that of patients
infected with other Gram-negative bacteria (83).
Individuals suffering from typhoid fever exhibit a distinct
peripheral blood metabolite profile, which has been elucidated by
both microarray and transcriptional profiling techniques (66, 84).
This profile diminishes following treatment and upon recovery the
majority of individuals exhibit a peripheral blood profile similar
to that of uninfected controls. Those who do not develop a typical
peripheral blood profile following treatment may possess genetic
mutations that render them incapable of mounting an appropriate
immune response. These patients have been shown to be prone to
relapse, reinfection, and in some cases become carriers (66).
IMMUNODEFICIENCY
There has been no evidence to support a correlation with suscepti-
bility to typhoid fever and primary or acquired immunodeficiency.
This is in contrast to infection with NTS serovars where infection
causes high levels of morbidity and mortality in patients with pri-
mary or acquired immunodeficiencies such as HIV infection. It
has been proposed that this difference is attributed to the manner
in which signaling occurs via the PRRs. The production of IL-17
by T-helper 17 cells (Th17) among other cytokines (IL-21, IL-22,
and IL-26) is important for the dissemination of NTS serovars but
not S. Typhi (85, 86).
MODELS OF INFECTION
S. Typhi is a host-adapted pathogen, which infects humans caus-
ing typhoid fever. Investigating the interactions of this pathogen
with the host has proved challenging as there are few animal
models for typhoid fever that are of direct relevance to their
human infection counterpart. This problem has been partially
alleviated by the establishment of the murine S. Typhimurium
infection model, which has been used to study typhoid fever.
The immune responses and subsequent inflammation mounted
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by mice following an S. Typhimurium infection mimics those
observed in human patients with typhoid fever as well as the sub-
sequent intestinal pathology (87). Mice are inoculated orally or
systemically by intravenous or intraperitoneal injection in addi-
tion to optional streptomycin pre-treatment (88). S. Typhimurium
induced colitis in streptomycin-pre-treated mice is reminiscent of
many symptoms of the human infection counterpart including
epithelial ulceration and infiltration of PMN/CD18(+) cells (89).
A comparison between streptomycin-pre-treated and untreated
mice highlighted the drastic influence of streptomycin on resis-
tance to colonization by S. Typhimurium whereby 100% of treated
and none of the untreated mice excreted the bacterium in their
feces (90). A disease with features reminiscent of typhoid fever
can be observed in BALB/c or C57BL/6 mice when inoculated
with S. Typhimurium due to a mutation in the SLC11A1 gene,
which encodes natural resistance-associated macrophage protein
one (Nramp1). In contrast to this, chronic and persistent car-
rier states of infection can be studied using Nramp+/+ mice
as they are resistant to infection with S. Typhimurium (25, 88).
However, there has been no correlation identified in humans
between Nramp alleles and susceptibility to typhoid fever as S.
Typhimurium causes less severe disease symptoms in humans to
that of S. Typhi. As a result, conclusions drawn from animal exper-
iments must be interpreted carefully (91). Furthermore, it has been
reported that tlr11−/−mice are more susceptible to infection by S.
Typhimurium and can be infected with S. Typhi, which typically
does not cause infection as TRL11 is normally expressed in mice
but not in humans (92). Recently, an alternative S. Typhi murine
model, which resembles human typhoid fever, was established
using non-obese diabetic (NOD)-SCID IL2rγnull mice, which have
been humanized by engrafting human hematopoietic stem cells
(hu–SRC–SCID mice). This model results in lethal infection with
inflammatory and pathological responses, which mimic human
typhoid fever (93).
As well as murine models of infection, the larvae of the
wax moth Galleria mellonella (G. mellonella) have been used to
study host–pathogen interactions with Salmonella species. Iso-
genic mutant strains of S. Typhimurium lacking known virulence
determinants were tested to identify their role in pathogenicity.
Interestingly, mutants depleted of either or both SPI encoded
T3SS-1 and T3SS-2 exhibited no alterations in their virulence
phenotype. Attenuation of the PhoPQ two-component signal
transduction system resulted in reduced pathogenicity due to
the lack of phoQ (94). As reported in murine models, muta-
tions in the hfq gene, which encodes the chaperone protein Hfq
that plays an important role in the binding of regulatory sRNA
transcripts to their antisense targets attenuated the pathogenicity
of S. Typhimurium in G. mellonella. Endoribonuclease RNase E
and RNase III mutants show an attenuated virulence phenotype
including impairment in motility and reduced proliferation inside
G. mellonella (95).
Recently, zebrafish (Danio rerio) models have provided a
unique opportunity to study the function of phagocytic cells such
as neutrophils and macrophages. Transgenic zebrafish lines with
fluorescently labeled leukocyte populations enable non-invasive
imaging of the mechanisms by which different pathogens inter-
act with macrophages and evade the host innate immunity (96).
Similarly, 28 h old zebrafish embryos infected with DsRed labeled
S. Typhimurium allowed for the precise location of the pathogen to
be determined in a living host over a 3 day time course using mul-
tidimensional digital imaging microscopy. Lethal infection with S.
Typhimurium residing and proliferating in both the endothelium
layer of blood vessels and macrophages was observed (97).
FUTURE PERSPECTIVES
To date, there have been many studies elucidating the complex
Salmonella–host interactome. Our understanding of the viru-
lence determinants of Salmonella species and their mechanisms
of action has been extended by the utilization of murine, G.
mellonella, and zebrafish models of S. Typhimurium infection in
addition to ex vivo cell culture methods. Despite this, further work
is needed to determine the specific contribution of many of these
regulators and virulence factors for which clear functions and roles
have yet to be defined. Characterizing the pathogenesis of salmo-
nellosis will be crucial to the development and implementation of
future therapeutic strategies to treat this illness. The importance of
which has been recently highlighted in reports on the emergence
of antimicrobial resistance in Salmonella and many other bacterial
pathogens (98).
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